What has been discovered by the scientific community is that the spike protein alone is almost entirely responsible for the damage to the cardiovascular system if it gets into circulation. The assumption of this vaccine was that it should behave like traditional vaccines and remain in the area of the injection site, the shoulder, and activate the immune system in that area.
However, through a FOIA request submitted via a Japanese regulatory agency, Dr. Bridle and his international colleagues have obtained access to a biodistribution study. This study relates to where mRNA vaccines infect what parts of the body. The short answer is that the mRNA does not remain localized in the injection site of the shoulder muscle. The spike protein is a pathogenic protein that is a toxin and cause damage to the body. The spike protein gets into the bloodstream over several days post vaccination and accumulates in the spleen, the bone marrow, the liver, the adrenal glands, the ovaries, the heart, and can bind onto platelets and blood vessel lining cells which can cause platelets to clump (leading to clots) and can lead to bleeding. It can also cross the blood-brain barrier and cause neurological damage.
There is unpublished evidence suggesting that not only the antibodies from the vaccine can transfer through breast milk, but also the viral spike mRNA into breastfed infants. The USA adverse event database shows evidence of suckling infants suffering from bleeding disorders in the gastrointestinal tract. The Canadian Blood Service is currently allowing vaccinated people to donate blood. This presents a risk of transfer of pathogenic spike proteins to fragile patients.
This has serious implications for people whom SARS CoV-2 is not a high risk pathogen which includes youth. This has risk of rendering some people infertile.
In the interview Dr. Bridle made no comment alluding to shedding. He does allude to making his statements available in print soon. This is about the implications of when the spike protein (and the genetic code to build it) leaves the local, small area of the injection area tissue (shoulder muscle) and enters the circulation system, the blood.
Summary of interview
What has been discovered by the scientific community is that the spike protein alone is almost entirely responsible for the damage to the cardiovascular system if it gets into circulation. The assumption of this vaccine was that it should behave like traditional vaccines and remain in the area of the injection site, the shoulder, and activate the immune system in that area.
However, through a FOIA request submitted via a Japanese regulatory agency, Dr. Bridle and his international colleagues have obtained access to a biodistribution study. This study relates to where mRNA vaccines infect what parts of the body. The short answer is that the mRNA does not remain localized in the injection site of the shoulder muscle. The spike protein is a pathogenic protein that is a toxin and cause damage to the body. The spike protein gets into the bloodstream over several days post vaccination and accumulates in the spleen, the bone marrow, the liver, the adrenal glands, the ovaries, the heart, and can bind onto platelets and blood vessel lining cells which can cause platelets to clump (leading to clots) and can lead to bleeding. It can also cross the blood-brain barrier and cause neurological damage.
There is unpublished evidence suggesting that not only the antibodies from the vaccine can transfer through breast milk, but also the viral spike mRNA into breastfed infants. The USA adverse event database shows evidence of suckling infants suffering from bleeding disorders in the gastrointestinal tract. The Canadian Blood Service is currently allowing vaccinated people to donate blood. This presents a risk of transfer of pathogenic spike proteins to fragile patients.
This has serious implications for people whom SARS CoV-2 is not a high risk pathogen which includes youth. This has risk of rendering some people infertile.
In the interview Dr. Bridle made no comment alluding to shedding. He does allude to making his statements available in print soon. This is about the implications of when the spike protein (and the genetic code to build it) leaves the local, small area of the injection area tissue (shoulder muscle) and enters the circulation system, the blood.